Clicky

Pulmonx Corporation(LUNG)

Description: Pulmonx Corporation, a medical technology company, designs, develops, manufactures, and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in Europe, the Middle East, Africa, the Asia-Pacific, the United States, and internationally. Pulmonx Corporation was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. The company was incorporated in 1995 and is headquartered in Redwood City, California.


Keywords: Medicine Clinical Medicine Medical Technology Catheter Inflation Tomography Chronic Obstructive Pulmonary Disease Valves Pulmonary Disease Pulmonology Balloon Catheter Treatment Of Chronic Obstructive Pulmonary Disease Invasive Medical Devices Lung Minimally Invasive Medical Devices Bronchus Treatment Of Chronic Obstructive Pulmonary Diseases

Home Page: pulmonx.com

LUNG Technical Analysis

700 Chesapeake Drive
Redwood City, CA 94063
United States
Phone: 650 364 0400


Officers

Name Title
Mr. Glendon E. French CEO, Pres & Director
Mr. David A. Lehman Gen. Counsel & Sec.
Mr. Geoffrey Beran Rose Chief Commercial Officer
Dr. Derrick Sung Ph.D. Chief Financial Officer
Mr. Sri Radhakrishnan Chief Technical Officer
Ms. Lauren Cristina VP of Fin. & Admin. (U.S.)
Ms. Marcee M. Maroney VP of Marketing
Sarah Huber VP of Sales (U.S.)
Ms. Lisa Paul Chief People Officer
Mr. Jérôme Erath Sr. VP & GM of Europe Middle-East & Africa

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 28.3286
Trailing PE: 0
Price-to-Book MRQ: 1.3615
Price-to-Sales TTM: 5.142
IPO Date: 2020-10-01
Fiscal Year End: December
Full Time Employees: 253
Back to stocks